Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TBE Vaccine Booster in Obese Persons
NCT04017052Phase 4Unknown
- Sponsor
- Medical University of Vienna
- Start
- Apr 2015
- Primary completion
- Feb 2020
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of FSME-IMMUN in tick-borne encephalitis (TBE), sponsored by Medical University of Vienna. Status: unknown.
02
Drugs
FSME-IMMUN
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on NCT04017052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04017052.